Home / Dallah Healthcare Co. / 2024 Annual Results

Dallah Healthcare Co. 2024 Annual Results

Revenue

SAR 3.21B

Net Profit

SAR 485M

EPS

SAR 4.83

Operating Cash Flow

SAR 678M

Dallah Healthcare Co. (4004) reported full year 2024 revenue of SAR 3.21B, up 8.9% from SAR 2.94B in 2023. Net profit came in at SAR 485M, up 25.9% year on year. Earnings per share were SAR 4.83. The company generated SAR 678M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 1.40 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 1.40.

Key Financial Metrics

Metric	2024	2023
Revenue	SAR 3.21B	SAR 2.94B
Net Profit	SAR 485M	SAR 385M
Net Margin	15.1%	13.1%
ROE	14.0%	12.0%
EPS	SAR 4.83	SAR 3.70
Total Assets	SAR 6.61B	SAR 6.24B
Total Equity	SAR 3.47B	SAR 3.20B
Total Liabilities	SAR 2.87B	SAR 2.77B
Operating Cash Flow	SAR 678M	SAR 626M

Year on Year Comparison

Revenue increased by 8.9% compared to 2023. Net profit increased by 25.9%. Both revenue and profit grew — indicating expanding business.

View full company profile →

View all years:

2024 2023 2022 2021 2020 2019

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2025-04-15.